Hepatitis C virus-genotype 4
Treatment of hepatitis C virus genotype 4 in the DAA era
... of hepatitis C virus infection (HCV) [1, ...to genotype 4 (GT4) HCV in clinical trials and field-practice studies compared with other genotypes ...this genotype [5, ...treat ...
8
Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta analysis
... Our fi ndings are similar to results from large rando- mised controlled trials of PEG-IFN+RBV treatment. 8 9 However, the generalisability of these previous trials has been limited due to the paucity of HCV-4, ...
9
Emergence of Hepatitis C Virus Genotype 4: Phylogenetic Analysis Reveals Three Distinct Epidemiological Profiles
... The first epidemiological profile consists of immigrants from the Middle East and Africa, mainly Egyptian immigrants in- fected with HCV-4a in their home country. In the Amsterdam region, HCV-4a accounts for at least 35% ...
7
Implication of protein kinase R Gene quantification in hepatitis C Virus Genotype 4 induced Hepatocarcinogenesis
... The PKR activation pathway may be inhibited as a sur- vival benefit for the cancer cell. Increased PKR expres- sion has been documented in cancer cells, but its activity was in-fact decreased; therefore we can add that ...
8
Antisense oligonucleotide inhibition of hepatitis C virus genotype 4 replication in HepG2 cells
... with genotype 4 ...HCV genotype have not yet been ...vitro virus propagation is still hampering screening of antiviral activity of these molecules and the development of effective ...
9
Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4
... The study protocol conformed with the ethical guidelines of the 1975 Declaration of Helsinki and was reviewed and approved by the ethical committee of the Gastroenterology Surgical Centre, Faculty of Medicine, Mansoura ...
11
Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents
... by genotype or subtype (when available), their accession numbers, and their country of origin: AU, Australia; BE, Belgium; CA, Canada; CY, Cyprus; CN, China; EG, Egypt; ES, Spain; FR, France; GB, Great Britain; ...
11
Molecular Epidemiology of Hepatitis C Virus Genotype 4 Isolates in Egypt and Analysis of the Variability of Envelope Proteins E1 and E2 in Patients with Chronic Hepatitis
... Table 4, the variability could drastically alter epitope ...ciency virus type 1 (57), escape mutations that inhibit process- ing or HLA binding have been observed to occur more often in variable regions, ...
8
Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement
... LSM dropped from 15.6±10.8 to 12.1±8.7 kPa post-SVR; the maximum change of −5.8 occurred in F4 versus −2.79, −1.28 and +0.08 in F3, F2 and F0–F1 respectively (p<0.0001). At baseline, 41 patients were in the F4 group; ...
9
Hepatitis C Virus Genotype 1a Growth and Induction of Autophagy
... for 4 days in culture were detached from collagen-coated petri dishes by a brief trypsin treatment, pelleted in a microcentrifuge, and fixed in 4% paraformaldehyde and 1% glutaraldehyde in ...
10
Investigating the Origin and Spread of Hepatitis C Virus Genotype 5a
... HCV genotype 2 in Martinique (17), HCV genotype 4 strains in Cameroon (21), and HCV genotype 6 in Southeast Asia (35), the endemic pool of HCV genotype 5a has not yet been ...HCV ...
7
Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir
... Limited in vitro data suggests that telaprevir has activ- ity against HCV G4 [13]. HCV G4 is highly heteroge- neous with up to 18 subtypes identified so far [4]. This large variation in subtype can affect disease ...
8
Prediction of T cell epitopes of hepatitis C virus genotype 5a
... of genotype 5a (Table ...for genotype 2, while 5 other epitopes were conserved in either 2 or 3 geno- types ...in genotype 1a, 1b, 2 and 4 epitope variants at anchor residues position 2 and 9 ...
13
Potential role of interleukin 28B-gene polymorphism and natural immune enhancer treatment response in chronic HCV patients
... Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide, the available treatment nowadays for HCV is the combination of pegylated interferon and ribavirin, many ...
6
Management of hepatitis C genotype 4 in the directly acting antivirals era
... with hepatitis C virus (HCV) has revolutio- nised the fi ...treatment. 4 Whether or not even shorter regimens of 4 weeks could be used has recently been brought into question, although ...
10
Association of IL 10, IL 4, and IL 28B gene polymorphisms with spontaneous clearance of hepatitis C virus in a population from Rio de Janeiro
... GG genotype produce higher levels of IL-10 than GA or AA individuals ...AA genotype for IL-10 (−1082) was more frequently observed in patients with chronic hepatitis C when com- pared to those ...
6
Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution
... Commonly used molecular biology methods for HCV genotyping include DNA sequence assay (a gold stand- ard), type specific primers amplification method, restric- tion fragment length polymorphism (RFLP), gene chip assay, ...
14
Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment
... including genotype 1- and 4-infected cirrhotic patients (METAVIR score F3/4; n = 223), an SVR of 84 % was reported after treatment with daclatasvir and ...of genotype 1b cirrhotic patients (n ...
23
Safety and Efficacy of Sofosbuvir and Simeprevir Versus Sofosbuvir and Daclatasvir in Treatment of Naïve Egyptian Patients with Chronic Hepatitis C Virus Infection
... HCV genotype-4 infected patients and demonstrated that the SVR12 rate was up to 100% in patients treated for 12 weeks regardless of fibrosis stage and treatment ...
9
Challenging hepatitis C-infected liver transplant patients
... Donor-CC genotype recipients have increased liver enzymes, viral load, and rate of fibrosis, along with adverse outcomes such as cir- rhosis and need for ...recipient-CC genotype has the exact opposite ...
8